Biosurgical Agents – Market Insights – Japan

The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in biosurgical agents are used, rising awareness of the clinical benefits of these products on surgical outcomes, and the expanded indications in multiple procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the biosurgical agent market in Japan from 2019 through 2032.

Increasing surgical procedure volumes in Japan will largely dictate the growth of the overall market.

Which surgical procedures are expected to grow the most during the forecast period?

Which surgical specialties contribute most to biosurgical agent revenues in Japan?

The Japanese surgical hemostat market will grow over the forecast period.

What is driving the adoption of surgical hemostats in Japan?

Which companies are the leading competitors in these markets?

What strategies are companies employing to maintain their lead in the market?

Product penetration by surgical specialty will influence overall market trends.

Which specialty type has seen the highest overall penetration of biosurgical agents?

Which biosurgical agent materials are most popular and drive unit sales within each specialty?

Table of contents